Corvus Pharmaceuticals (CRVS) Non-Current Assets (2022 - 2025)
Historic Non-Current Assets for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Q3 2025 value amounting to $1.0 million.
- Corvus Pharmaceuticals' Non-Current Assets fell 2511.18% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 2511.18%. This contributed to the annual value of $1.3 million for FY2024, which is 777.86% down from last year.
- Per Corvus Pharmaceuticals' latest filing, its Non-Current Assets stood at $1.0 million for Q3 2025, which was down 2511.18% from $1.1 million recorded in Q2 2025.
- In the past 5 years, Corvus Pharmaceuticals' Non-Current Assets ranged from a high of $1.8 million in Q1 2022 and a low of $1.0 million during Q3 2025
- Over the past 4 years, Corvus Pharmaceuticals' median Non-Current Assets value was $1.3 million (recorded in 2024), while the average stood at $1.4 million.
- In the last 5 years, Corvus Pharmaceuticals' Non-Current Assets surged by 97.82% in 2024 and then tumbled by 2511.18% in 2025.
- Corvus Pharmaceuticals' Non-Current Assets (Quarter) stood at $1.7 million in 2022, then decreased by 13.62% to $1.4 million in 2023, then decreased by 7.78% to $1.3 million in 2024, then dropped by 23.63% to $1.0 million in 2025.
- Its last three reported values are $1.0 million in Q3 2025, $1.1 million for Q2 2025, and $1.2 million during Q1 2025.